Natglycan, LLC

Novab, Inc., located in Tucker, GA, is pioneering a new class of monoclonal antibodies that utilize a unique rigid sheet binding site, derived from ancient organisms, to target novel and distinct functionalities. Their innovative approach allows for the engineering of small single polypeptide antibodies capable of binding to glycans and developing multispecific antibodies for advanced detection and targeting of infectious agents and tumor cells. The company also leverages its Multimeric Ligand Technology to enhance antibody discovery and facilitate targeted delivery of therapeutic agents, including drugs and nucleic acids. With a leadership team that includes renowned immunologist Max D. Cooper, Novab is committed to advancing biomedical research and commercial applications in the realm of antibody technology. Generated from the website

Expression Therapeutics, Inc. is a fully integrated clinical stage gene and cell therapy company based in Tucker, GA. They specialize in developing novel, potentially curative therapeutics for deadly childhood and adult genetic diseases, utilizing their scientific breakthrough in transgene bioengineering and protein engineering to optimize gene therapy for various target indications such as bleeding disorders, primary immunodeficiencies, and cancer. With a multi-platform approach and a deep understanding of target diseases, Expression Therapeutics is a versatile drug development platform that is not limited to a specific technology. They have a state-of-the-art manufacturing facility capable of producing cGMP LV and AAV vectors, cell therapy products, and recombinant proteins, enabling them to expedite the development of their clinical programs.Generated from the website